These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29545182)

  • 1. A rat model of SHPT with bone abnormalities in CKD induced by adenine and a high phosphorus diet.
    Ni LH; Tang RN; Lv LL; Wu M; Wang B; Wang FM; Ni HF; Song KY; Wang LT; Meng-Zuo ; Chen Q; Liu BC
    Biochem Biophys Res Commun; 2018 Apr; 498(3):654-659. PubMed ID: 29545182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Sato H; Goto M; Nishimura G; Morimoto N; Tokushima H; Horii Y; Takahashi N
    Bone; 2023 Feb; 167():116613. PubMed ID: 36395959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiscale effects of the calcimimetic drug, etelcalcetide on bone health of rats with secondary hyperparathyroidism induced by chronic kidney disease.
    Sharma S; Kumar S; Tomar MS; Chauhan D; Kulkarni C; Rajput S; Sadhukhan S; Porwal K; Guha R; Shrivastava A; Gayen JR; Kumar N; Chattopadhyay N
    Bone; 2024 Aug; 185():117126. PubMed ID: 38777312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic kidney disease/bone and mineral metabolism: the imperfect storm.
    Williams ME
    Semin Nephrol; 2009 Mar; 29(2):97-104. PubMed ID: 19371800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of osteoporosis medications in a rat model of late-stage chronic kidney disease accompanied by secondary hyperparathyroidism and hyperphosphatemia.
    Ota M; Takahata M; Shimizu T; Kanehira Y; Kimura-Suda H; Kameda Y; Hamano H; Hiratsuka S; Sato D; Iwasaki N
    Osteoporos Int; 2017 Apr; 28(4):1481-1490. PubMed ID: 27933339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etelcalcetide, A Novel Calcimimetic, Prevents Vascular Calcification in A Rat Model of Renal Insufficiency with Secondary Hyperparathyroidism.
    Yu L; Tomlinson JE; Alexander ST; Hensley K; Han CY; Dwyer D; Stolina M; Dean C; Goodman WG; Richards WG; Li X
    Calcif Tissue Int; 2017 Dec; 101(6):641-653. PubMed ID: 29038882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging drugs for secondary hyperparathyroidism.
    Cozzolino M; Tomlinson J; Walsh L; Bellasi A
    Expert Opin Emerg Drugs; 2015 Jun; 20(2):197-208. PubMed ID: 25702624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dentoalveolar Alterations in an Adenine-Induced Chronic Kidney Disease Mouse Model.
    Mohamed FF; Amadeu de Oliveira F; Kinoshita Y; Yalamanchili RR; Eltilib LA; Andras NL; Narisawa S; Tani T; Chu EY; Millán JL; Foster BL
    J Bone Miner Res; 2023 Aug; 38(8):1192-1207. PubMed ID: 37191192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical and trabecular bone are equally affected in rats with renal failure and secondary hyperparathyroidism.
    Bajwa NM; Sanchez CP; Lindsey RC; Watt H; Mohan S
    BMC Nephrol; 2018 Feb; 19(1):24. PubMed ID: 29394885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies.
    Reiss AB; Miyawaki N; Moon J; Kasselman LJ; Voloshyna I; D'Avino R; De Leon J
    Atherosclerosis; 2018 Nov; 278():49-59. PubMed ID: 30253289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evocalcet prevents ectopic calcification and parathyroid hyperplasia in rats with secondary hyperparathyroidism.
    Sakai M; Tokunaga S; Kawai M; Murai M; Kobayashi M; Kitayama T; Saeki S; Kawata T
    PLoS One; 2020; 15(4):e0232428. PubMed ID: 32343734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The receptor activator of nuclear factor-kappaB ligand inhibitor osteoprotegerin is a bone-protective agent in a rat model of chronic renal insufficiency and hyperparathyroidism.
    Padagas J; Colloton M; Shalhoub V; Kostenuik P; Morony S; Munyakazi L; Guo M; Gianneschi D; Shatzen E; Geng Z; Tan HL; Dunstan C; Lacey D; Martin D
    Calcif Tissue Int; 2006 Jan; 78(1):35-44. PubMed ID: 16362459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe chronic kidney disease environment reduced calcium-sensing receptor expression in parathyroid glands of adenine-induced rats even without high phosphorus diet.
    Uchiyama T; Ohkido I; Nakashima A; Saito Y; Okabe M; Yokoo T
    BMC Nephrol; 2020 Jun; 21(1):219. PubMed ID: 32517664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of intermittent treatment with sevelamer hydrochloride on parathyroid hyperplasia and vascular calcification in rats with chronic kidney disease].
    Nagano N; Miyata S; Abe M; Wakita S; Kobayashi N; Wada M
    Clin Calcium; 2005 Sep; 15 Suppl 1():35-9; discussion 39-40. PubMed ID: 16272627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenine-induced chronic kidney disease induces a similar skeletal phenotype in male and female C57BL/6 mice with more severe deficits in cortical bone properties of male mice.
    Metzger CE; Swallow EA; Stacy AJ; Allen MR
    PLoS One; 2021; 16(4):e0250438. PubMed ID: 33891630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic kidney disease induced by adenine: a suitable model of growth retardation in uremia.
    Claramunt D; Gil-Peña H; Fuente R; García-López E; Loredo V; Hernández-Frías O; Ordoñez FA; Rodríguez-Suárez J; Santos F
    Am J Physiol Renal Physiol; 2015 Jul; 309(1):F57-62. PubMed ID: 25972508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure.
    Neves KR; Graciolli FG; dos Reis LM; Pasqualucci CA; Moysés RM; Jorgetti V
    Kidney Int; 2004 Dec; 66(6):2237-44. PubMed ID: 15569312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermethylation of the CaSR and VDR genes in the parathyroid glands in chronic kidney disease rats with high-phosphate diet.
    Uchiyama T; Tatsumi N; Kamejima S; Waku T; Ohkido I; Yokoyama K; Yokoo T; Okabe M
    Hum Cell; 2016 Oct; 29(4):155-61. PubMed ID: 27589858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.